Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001842952-25-000028
Filing Date
2025-03-20
Accepted
2025-03-20 16:15:27
Documents
71
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cntx-20241231.htm   iXBRL 10-K 1257346
2 EX-4.4 cntx-ex44to2024form10xk.htm EX-4.4 23189
3 EX-10.15 cntx-ex1015lonzafirstamend.htm EX-10.15 35133
4 EX-10.19 cntx-ex1019justxevotecxlin.htm EX-10.19 329316
5 EX-19 cntx-ex19insidertradingpol.htm EX-19 88887
6 EX-23.1 cntx-231cohnreznick10xkcon.htm EX-23.1 2624
7 EX-31.1 cntx2024ex311certification.htm EX-31.1 10742
8 EX-31.2 cntx2024ex312certification.htm EX-31.2 10744
9 EX-32.1 cntx2024ex321certification.htm EX-32.1 6474
15 cntx-20241231_g1.jpg GRAPHIC 801125
16 cntx-20241231_g2.jpg GRAPHIC 854749
17 cntx-20241231_g3.jpg GRAPHIC 290679
18 cntx-20241231_g4.jpg GRAPHIC 767272
  Complete submission text file 0001842952-25-000028.txt   12548864

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20241231.xsd EX-101.SCH 34619
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntx-20241231_cal.xml EX-101.CAL 44112
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntx-20241231_def.xml EX-101.DEF 147909
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20241231_lab.xml EX-101.LAB 526127
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20241231_pre.xml EX-101.PRE 349346
73 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20241231_htm.xml XML 484248
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40654 | Film No.: 25756623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)